Premium
Analysis of Chlamydia pneumoniae ‐specific oligoclonal bands in multiple sclerosis and other neurologic diseases
Author(s) -
Franciotta D.,
Zardini E.,
Bergamaschi R.,
Grimaldi L. M.,
Andreoni L.,
Cosi V.
Publication year - 2005
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.2005.00407.x
Subject(s) - multiple sclerosis , cerebrospinal fluid , immunology , chlamydia , chlamydiaceae , chlamydiales , medicine , chlamydophila pneumoniae , antibody , immune system , antigen , pathology
Objective – Paired serum and cerebrospinal fluid (CSF) specimens were investigated for Chlamydia pneumoniae ‐specific oligoclonal bands (OCBs) to determine band specificity in multiple sclerosis (MS). Material and methods – Serum and CSF samples were collected from patients with relapsing–remitting MS ( n = 56), other inflammatory ( n = 18) or non‐inflammatory ( n = 15) neurologic diseases, and from 10 healthy controls. OCBs were determined with affinity immunoblotting of C. pneumoniae ‐specific IgG onto antigen‐coated nitrocellulose paper after protein separation with agarose isoelectric focusing. Results – Chlamydia pneumoniae ‐specific OCBs were present in 5 of 56 patients with MS, and in 3 of 18 patients with other inflammatory neurologic diseases. Conclusions – The intrathecal production of C. pneumoniae ‐specific oligoclonal IgG occurs in a minority of patients with MS. This intrathecal anti‐ C. pneumoniae reactivity is likely part of a polyspecific humoral immune response in MS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom